Investors

Dr. Ashleys Limited is a global pharmaceutical company, together with its subsidiaries, specializing in the development, manufacturing, and supply of Active Pharmaceutical Ingredients (“API” ) and intermediates for special therapeutic treatment areas, and provides contract development and manufacturing services (“CDMO”) to its clients. Founded in 2012, the Company operates as a fully integrated partner to pharmaceutical and biotechnology firms worldwide.